Trevi Therapeutics
TRVI
#4553
Rank
$2.54 B
Marketcap
$17.90
Share price
-1.92%
Change (1 day)
138.99%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -$47.39 Million USD

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$43.95 Million USD, an increase over its 2024 earnings that were of -$47.94 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$47.39 Million7.83%
2025 -$43.95 Million-8.34%
2024 -$47.94 Million67%
2023 -$28.71 Million2.43%
2022 -$28.03 Million-14.45%
2021 -$32.76 Million1.36%
2020 -$32.32 Million23.64%
2019 -$26.14 Million27.54%
2018 -$20.5 Million